Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 37
Results: 15
ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4387, doi. 10.1038/onc.2012.462
- By:
- Publication type:
- Article
Renal disease appears not to affect carcinogenesis in CD151-null mice.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4458, doi. 10.1038/onc.2013.79
- By:
- Publication type:
- Article
Disruption of epithelial architecture caused by loss of PTEN or by oncogenic mutant p110α/PIK3CA but not by HER2 or mutant AKT1.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4417, doi. 10.1038/onc.2012.459
- By:
- Publication type:
- Article
Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4427, doi. 10.1038/onc.2012.446
- By:
- Publication type:
- Article
Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4331, doi. 10.1038/onc.2012.469
- By:
- Publication type:
- Article
A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4406, doi. 10.1038/onc.2012.460
- By:
- Publication type:
- Article
The mutant p53 mouse as a pre-clinical model.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4325, doi. 10.1038/onc.2012.610
- By:
- Publication type:
- Article
Renal disease as a potential compounding factor in carcinogenesis experiments with Cd151-null mice.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4457, doi. 10.1038/onc.2013.73
- By:
- Publication type:
- Article
NBN Phosphorylation regulates the accumulation of MRN and ATM at sites of DNA double-strand breaks.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4448, doi. 10.1038/onc.2012.443
- By:
- Publication type:
- Article
The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4377, doi. 10.1038/onc.2012.464
- By:
- Publication type:
- Article
Mesenchymal stem cells promote growth and angiogenesis of tumors in mice.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4343, doi. 10.1038/onc.2012.458
- By:
- Publication type:
- Article
Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4366, doi. 10.1038/onc.2012.471
- By:
- Publication type:
- Article
Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4355, doi. 10.1038/onc.2012.475
- By:
- Publication type:
- Article
Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/Snail signaling pathway.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4436, doi. 10.1038/onc.2012.444
- By:
- Publication type:
- Article
NANOG modulates stemness in human colorectal cancer.
- Published in:
- Oncogene, 2013, v. 32, n. 37, p. 4397, doi. 10.1038/onc.2012.461
- By:
- Publication type:
- Article